Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgkin Lymphoma, Follicular Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00054236
What this trial is testing

Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
Case Comprehensive Cancer Center 55
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Early research (Phase 1)Looking for participantsNCT06980116
What this trial is testing

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

Who this might be right for
Relapsed or Refractory B-cell MalignanciesChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Follicular Lymphoma (FL)+4 more
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 85
Early research (Phase 1)UnknownNCT00004036
What this trial is testing

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more
The Cleveland Clinic 30
Post-approval studies (Phase 4)UnknownNCT01805232
What this trial is testing

Intravenous Artesunate and Malaria

Who this might be right for
Malaria
University of Khartoum 80
Early research (Phase 1)Study completedNCT06352528
What this trial is testing

Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Severe Hepatic Impairment

Who this might be right for
Hepatic ImpairmentHealthy Volunteers
Bristol-Myers Squibb 18
Large-scale testing (Phase 3)UnknownNCT04873414
What this trial is testing

Convalescent Plasma as Adjunct Therapy for COVID-19

Who this might be right for
COVID-19
National Institute of Health Research and Development, Ministry of Health Republic of Indonesia 364
Not applicableLooking for participantsNCT06784167
What this trial is testing

Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment

Who this might be right for
Chronic Lymphocytic LeukemiaDiffuse Large B-Cell LymphomaFollicular Lymphoma+4 more
OHSU Knight Cancer Institute 45
Testing effectiveness (Phase 2)UnknownNCT03600363
What this trial is testing

A Clinical Trial of Metformin in the Maintenance of Non-Hodgkin's Lymphoma Patients

Who this might be right for
Lymphoma, Large B-Cell, DiffuseStage III Follicular Lymphoma
Ruijin Hospital 250
Early research (Phase 1)Study completedNCT00641381
What this trial is testing

Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 25
Large-scale testing (Phase 3)Looking for participantsNCT06784752
What this trial is testing

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Who this might be right for
Somatostatin Receptor Positive (SSTR+)Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Novartis Pharmaceuticals 240
Testing effectiveness (Phase 2)Looking for participantsNCT06852638
What this trial is testing

CD70-targeted immunoPET Imaging of Malignant Cancers

Who this might be right for
Renal CancerRenal Clear Cell CarcinomaLymphoma+4 more
RenJi Hospital 300
Testing effectiveness (Phase 2)Study completedNCT02723071
What this trial is testing

Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 48
Testing effectiveness (Phase 2)Looking for participantsNCT05389293
What this trial is testing

Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Who this might be right for
Follicular LymphomaLymphoma
Memorial Sloan Kettering Cancer Center 152
Testing effectiveness (Phase 2)Ended earlyNCT04205838
What this trial is testing

Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedHigh Grade B-Cell LymphomaProgressive Disease+8 more
Jonsson Comprehensive Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT00676832
What this trial is testing

Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Prometheus Laboratories 190
Not applicableLooking for participantsNCT06832306
What this trial is testing

STimulation to Activate RespIration

Who this might be right for
ARDS (Moderate or Severe)AHRFMechanically Ventilated ICU Patients
Lungpacer Medical Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT00057447
What this trial is testing

Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients

Who this might be right for
Non-Hodgkin's Lymphoma
InterMune 24
Large-scale testing (Phase 3)Ended earlyNCT00014326
What this trial is testing

Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
European Organisation for Research and Treatment of Cancer - EORTC 204
Testing effectiveness (Phase 2)Study completedNCT00867529
What this trial is testing

Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma

Who this might be right for
B-cell Adult Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic Leukemia+35 more
Fred Hutchinson Cancer Center 63
Next Page